Abendroth C S, Wang H H, Ducatman B S
Department of Pathology, Beth Israel Hospital, Boston, Massachusetts 02215.
Am J Clin Pathol. 1991 Nov;96(5):654-9. doi: 10.1093/ajcp/96.5.654.
With the use of fine-needle aspiration biopsy to evaluate non-palpable breast lesions, an increasing number of cases of ductal carcinoma in situ (DCIS) are encountered. The authors previously demonstrated that it is not possible to distinguish definitively between DCIS and invasive ductal carcinoma on fine-needle aspiration biopsy. To determine whether DCIS could be separated from atypical ductal hyperplasia (ADH), the authors identified all cases of exclusive DCIS or ADH with fine-needle aspiration biopsy before surgery. Sixteen cases of ADH and 19 cases of DCIS were identified. Of these, 12 in each category were sufficiently cellular to allow evaluation of architectural and cytologic features. Cases of ADH were more likely to be diagnosed as negative or atypical (11 of 12); in contrast, DCIS was more likely to be designated as suspicious or positive (9 of 12). Architectural and cytologic features characteristic of ADH included cells arranged in flat cohesive sheets, distinct cell borders, and myoepithelial cells. Those features characteristic of DCIS were single cells representing more than 10% of atypical cells, cellular dyshesion, and inflammatory background, coarsely granular chromatin, and nuclear pleomorphism. Many other features were not useful in separating ADH from DCIS. Based on this small series, it appears that the distinction between some cases of DCIS and ADH may be possible on fine-needle aspiration biopsy.
随着细针穿刺活检用于评估不可触及的乳腺病变,原位导管癌(DCIS)的病例数日益增多。作者先前已证明,在细针穿刺活检中无法明确区分DCIS和浸润性导管癌。为了确定DCIS是否能与非典型导管增生(ADH)区分开来,作者在手术前通过细针穿刺活检识别出所有单纯DCIS或ADH病例。共识别出16例ADH和19例DCIS。其中,每类各有12例细胞量充足,足以评估结构和细胞学特征。ADH病例更有可能被诊断为阴性或非典型(12例中的11例);相比之下,DCIS更有可能被判定为可疑或阳性(12例中的9例)。ADH的结构和细胞学特征包括细胞呈扁平黏附片状排列、细胞边界清晰以及肌上皮细胞。DCIS的特征为单个细胞占非典型细胞的10%以上、细胞黏附丧失、炎症背景、染色质粗糙颗粒状以及核多形性。许多其他特征在区分ADH和DCIS方面并无用处。基于这一小系列病例,似乎在细针穿刺活检中有可能区分某些DCIS和ADH病例。